Epratuzumab ( 依帕珠单抗 )

产品名称：Epratuzumab ( 依帕珠单抗 )；

产品编号：YR1021；

分子名称：Epratuzumab；

克隆性：Monoclonal；

产品别称：90Y-DOTA-hLL2；

关键词：Epratuzumab, LymphoCide, 205923-57-5, AMG 412, hLL2, DB04958CD22, CD22 molecule, CD22 antigen, B-cell receptor CD22, sialic acid binding Ig like lectin 2, SIGLEC 2, SIGLEC2, BL-CAM, T-cell surface antigen Leu-14, B-lymphocyte cell adhesion molecule, sialic acid binding90Y-DOTA-hLL2, 90Y-epratuzumab tetraxetan, AMG-412, 90Y-hLL2, hLL2, 依帕珠单抗；

规格：1mg, 5mg；

浓度：1mg/ml；

抗体亚型：IgG1；

宿主：Mouse；

CAS号：205923-57-5；

来源：CHO Cells；

纯度：≥95% as determined by SDS-PAGE；

缓冲体系：Supplied in PBS, PH7.5；

分子量：；

产品背景：Epratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE).；

保存条件：Stored at -20℃ to -80℃.；

运输条件：Shipped on ice packs.；

产品应用：IF, IP, Neut, FuncS, ELISA, FC, ICC, Activ, WB；